HDAC inhibitors highly alter the metabolic state of glioblastoma cell lines [37], and a similar mechanism in chondrosarcoma could underlie the sensitization to the glutaminolytic pathway inhibitors chloroquine and metformin. The gene discussed is HDAC9; the disease is glioblastoma.